These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 23197675)

  • 1. Distortion-product otoacoustic emission tests evaluate cochlear function and differentiate cochlear and vestibular schwannoma.
    Kagoya R; Shinogami M; Kohno M; Yamasoba T
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):267-71. PubMed ID: 23197675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of cochlear function with distortion products of otoacoustic emissions in acoustic neuroma].
    Oeken J
    HNO; 1996 Dec; 44(12):677-84. PubMed ID: 9081952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Otoacoustic emission and auditory efferent function testing in normal subjects and patients with sensori-neural hearing loss].
    Liang F; Liu C; Liu B
    Zhonghua Yi Xue Za Zhi; 1996 Oct; 76(10):763-6. PubMed ID: 9275520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased amplitudes of distortion product otoacoustic emissions in patients with unilateral acoustic neuroma.
    Gouveris H; Mann W
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):302-5. PubMed ID: 15668528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transitory evoked otoacoustic emissions in patients with cerebellopontile angle tumors].
    Pröschel U; Eysholdt U; Berg M
    HNO; 1994 Apr; 42(4):229-32. PubMed ID: 8021159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small vestibular schwannoma arising from the inferior vestibular nerve.
    Baguley DM; Jones SE; Moffat DA
    J Laryngol Otol; 2003 Jun; 117(6):498-500. PubMed ID: 12818063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear microphonics for hearing preservation in vestibular schwannoma surgery.
    Noguchi Y; Komatsuzaki A; Nishida H
    Laryngoscope; 1999 Dec; 109(12):1982-7. PubMed ID: 10591359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of cochlear hearing status in dogs using evoked otoacoustic emissions.
    Gonçalves R; McBrearty A; Pratola L; Calvo G; Anderson TJ; Penderis J
    J Small Anim Pract; 2012 Jun; 53(6):344-51. PubMed ID: 22647213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
    Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
    Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Discrimination of Hearing Disorder by Means of CLS and OAE in Vestibular Schwannoma].
    Börner E; Guntinas-Lichius O; Eßer D; Baljić I
    Laryngorhinootologie; 2016 Mar; 95(3):182-91. PubMed ID: 26135119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acoustic stimuli used for vestibular evoked myogenic potential studies on the cochlear function.
    Krause E; Mayerhofer A; Gürkov R; Drexl M; Braun T; Olzowy B; Boetzel K
    Otol Neurotol; 2013 Sep; 34(7):1186-92. PubMed ID: 23921920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial auditory neuropathy.
    Wang Q; Gu R; Han D; Yang W
    Laryngoscope; 2003 Sep; 113(9):1623-9. PubMed ID: 12972945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Otoacoustic emission and auditory efferent function testing in patients with sensori-neural hearing loss.
    Liang F; Liu C; Liu B
    Chin Med J (Engl); 1997 Feb; 110(2):139-41. PubMed ID: 9594286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acoustic distortion product recording in patients with sensorineural hearing loss].
    Pérez del Valle B; Morant Ventura A; Contreras Castelló A; Orts Albors M; Marco Algarra J
    Acta Otorrinolaringol Esp; 1996; 47(2):111-8. PubMed ID: 8695198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.